Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan and Amlodipine Tablets vs Irbesartan in Primary Hypertension (China, Phase III)
CTR20232886Phase 3Completed
- Sponsor
- Beijing Baiao Pharmaceuticals
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + amlodipine in essential hypertension, sponsored by Beijing Baiao Pharmaceuticals. Started Sep 2023; status: completed.
02
Drugs
irbesartan + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20232886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232886.